4//SEC Filing
SIEGALL CLAY B 4
Accession 0001415889-25-009017
CIK 0001472012other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:03 PM ET
Size
4.9 KB
Accession
0001415889-25-009017
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-03-26$7.29/sh+137,100$999,459→ 806,736 total
Footnotes (1)
- [F1]The weighted average purchase price for the transaction report was $7.29, and the range of prices were between $7.16 and $7.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001167496
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:03 PM ET
- Size
- 4.9 KB